United Kingdom· GB-APID-16240211000001108
Sandostatin 100micrograms/1ml solution for injection ampoules
A octreotide product containing octreotide, registered in United Kingdom by Lexon (UK) Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Octreotide is registered in 17 of 19 countries.
Countries holding a registration under ATC H01CB02 (octreotide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Octreotide · ATC H01CB02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of octreotide costs, country by country.
Normalised to the WHO defined daily dose (0.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Octreotide · price per daily dose (0.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$41.46
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Octreotide
- Manufacturer
- Lexon (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- H01CB02
- ATC class
- Octreotide
- Defined daily dose
- 0.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
367 interactions on record for octreotide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Octreotide · interactions on record
367 records
- 4 severe
- 151 moderate
- 4 minor
- 168 info
Most severe, free to view
- LonafarnibA16AX20severe
- PexidartinibL01EX15severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Octreotide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenOctreotide Bijon 10 mg Pulver och vätska till injektionsvätska, depotsuspensionUAB BIJON medica
- United StatesBYNFEZIA PenSun Pharmaceutical Industries, Inc.
- BelgiumMycapssa 20 mgAmryt Pharmaceuticals DAC
- CzechiaOCTREOTIDE TEVATeva B.V., Haarlem
- NetherlandsOctreotide Bendalis 0,05 mg/ml, oplossing voor injectieBendalis GmbH
- FinlandMycapssaAmryt Pharmaceuticals DAC
- ItalyOCTREOTIDE BIOINDUSTRIA LIMBIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI S.P.A.
- GermanyOctreo RatiopharmRatiopharm Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Octreotide Ratiopharm, Sandostatin
- Belgium · Octreoteva Long Acting, Octreotide Qilu
- Bulgaria · Octreotid Lyomark, Октреотид Lai Тева
- Cyprus · Octreotide Rompharm, Sandostatin
- Czechia · Octreotide Teva, Octreotide Teva B.V.
- Germany · Octreo Ratiopharm, Octreotid Bendalis
- Denmark · Octreoanne, Octreotid Sun
- Estonia · Octreotide Teva, Sandostatin
- Spain · Octreotida Gp-Pharm, Octreotida Sun
- Finland · Octreotide Orion, Octreotide Ratiopharm
- France · Octreotide Arrow, Octreotide Hospira
- Greece · Okrodin, Sandostatin
- Croatia · Oktreotid Teva, Sandostatin
- Hungary · Oktreotid Teva, Sandostatin
- Ireland · Octreotide Pfizer Healthcare Ireland, Olatuton
- Iceland · Octreoanne, Oczyesa
- Italy · Octreotide Bioindustria L.I.M., Octreotide Sun
- Liechtenstein · Oczyesa
- Lithuania · Octreotide Teva, Sandostatin
- Luxembourg · Octreoteva Long Acting, Sandostatine
- Latvia · Sandostatin, Sandostatin Lar
- Malta · Sandostatin, Sandostatin Lar
- Netherlands · Octreotide Bendalis, Octreotide Depot Teva
- Norway · Octreoanne, Octreotide Orion
- Poland · Okteva, Sandostatin
- Portugal · Octreotido Color, Octreotido Depot Teva
- Romania · Octreotidă Rompharm, Octreotidă Teva
- Sweden · Octreotide Orion, Octreotide Teva
- Slovenia · Oktreotid Teva, Sandostatin
- Slovakia · Sandostatin, Sandostatin Lar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e66e9334-aeb7-45a3-81d2-0075954cd280 GET /v1/drugs/e66e9334-aeb7-45a3-81d2-0075954cd280?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "16240211000001108",
"desc": "Sandostatin 100micrograms/1ml solution for injection ampoules (Lexon (UK) Ltd)",
"form": "Solution for injection",
"vpid": "36029411000001108",
"source": "dmd",
"vtm_id": "776970008",
"strength": "100 microgram",
"substance": "Octreotide",
"ingredient": "Octreotide acetate",
"supplier_code": "3415501000001104"
}See everything about octreotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.